BioPharma Pharma & Biopharma Manufacturing
Cytiva Launches Sefia: Advanced Platform to Transform CAR T Cell Therapy Manufacturing
Sefia cell therapy manufacturing platform comes out of Cytiva's extensive R&D expertise and in-depth understanding of CAR T manufacturing Automation...
May 30, 2024 | News
Eli Lilly Doubles Investment in Indiana Manufacturing Site with New $5.3 Billion Commitment
Eli Lilly and Company announced that it has more than doubled its investment in its Lebanon, Indiana, manufacturing site with a new $5.3 bi...
May 28, 2024 | News
Merck Acquires Mirus Bio for $600 Million to Strengthen Viral Vector Manufacturing Capabilities
Acquisition will advance Merck’s integrated offering for viral vector manufacturing Complements existing portfolio for development and production ...
May 23, 2024 | News
Touchlight Genetics and NPL Receive Innovate UK Funding for Advanced Gene Therapy Technology
Touchlight Genetics, in partnership with the National Physical Laboratory (NPL) have secured funding from Innovate UK under their Innovative Technologies: ...
May 13, 2024 | News
Ribobay Pharma Partners with Cytiva to Launch Pioneering Oligonucleotide Manufacturing Platform in China
Ribobay Pharma, a leading Chinese biopharmaceutical contract research, development, and manufacturing organization (CRDMO) and a spin-off company of Genera...
May 09, 2024 | News
WuXi AppTec Reports First Quarter 2024 Financial Results: Solid Performance with Continued Growth in R&D Services
First Quarter 2024 Financial Highlights: Revenue of RMB 7,982 million, with a slight decrease of 1.8% in non-COVID-19 commercial projects, underscoring ...
April 30, 2024 | Company results
AGC Biologics Completes Production of VAR2 Pharmaceuticals' Cancer-Targeting Antibodies
AGC Biologics announced the completion of work with VAR2 Pharmaceuticals on the production of the company’s two antibody candidates targeti...
April 25, 2024 | News
AGC Biologics Expands in Yokohama with Advanced Biomanufacturing Hub Featuring Cytiva Technology
New AGC Biologics facility in Yokohama strengthens access to world-class biomanufacturing in Japan, offering mammalian, mRNA and cell therapy ser...
April 23, 2024 | News
WuXi AppTec's Changzhou Facility Gains PMDA Approval, Bolstering Global Expansion Plans
Latest regulatory approval follows on the back of expansion plans announced during DCAT 2024 With peptides, oligos and peptide conjugates continui...
April 22, 2024 | News
Merck Launches First All-in-One Genetic Stability Assay to Accelerate Biosafety Testing
Proprietary Aptegra™ platform reduces five assays to one Results in 66% faster testing time and significantly lower cost for clients compared to t...
April 17, 2024 | News
Bloomage Secures Global Trust with Comprehensive Compliance, Passing Japan's PMDA Audit and Other International Inspections
Bloomage recently successfully completed the on-site Good Manufacturing Practice (GMP) audit conducted by Japan's Pharmaceuticals and M...
April 16, 2024 | Regulatory
AHF Denounces Moderna’s Backtracking on African mRNA Factory as a Blow to Global Health Equity
In a scathing rebuke, the AIDS Healthcare Foundation (AHF) has criticized Moderna for suspending its plans to build a state-of-the-art mRNA manufacturing f...
April 15, 2024 | News
Invenra and Catalent Forge Partnership to Advance Cancer Treatment Innovations
Invenra Inc., an innovative leader in bispecific antibody technology, is pleased to announce a strategic collaboration with Catalent, a global Contract Dev...
April 03, 2024 | News
Grindeks Expands Global Footprint with New Subsidiaries and Innovative Product Pipeline
In a strategic move to broaden its international market presence, Grindeks has successfully established 28 subsidiaries across Eu...
April 03, 2024 | News
Most Read
- Why Cell Therapy Systems Are Going Automatic: A New Era of Manufacturing
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Ravindra Rao Joins GOBI Technologies as Director of Life Sciences – APAC
- Amgen Announces $900 Million Expansion of Ohio Biomanufacturing Facility, Boosting Investment to Over $1.4 Billion
- Thermo Fisher Scientific Appoints Former CVS Health CEO Karen S. Lynch to Board of Directors
- Merck KGaA Reshapes Leadership for the Future with Key Executive Moves
- Aarian Health Appoints Thomas Keller as Business Director to Drive Innovation and Growth
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
News
